Skip to main content

Table 2 Comparison of 90-day outcome between patients under GA and CS

From: Effect of anesthesia strategy during endovascular therapy on 90-day outcomes in acute basilar artery occlusion: a retrospective observational study

Outcome variable GA CS Univariate analysis Multivariable analysis
Model 1 Model 2 Model 3
cOR (95% CI) P value aOR (95% CI) P value aOR (95% CI) P value aOR (95% CI) P value
Functional independence (mRS 0–2) at 90 days 43/139 (30.9) 24/39 (61.5) 0.28(0.13–0.59) < 0.01 0.31(0.13–0.75) 0.01 0.29 (0.09–0.97) 0.045 0.31(0.10–0.97) 0.045 *
Favorable outcome (mRS 0–3) at 90 days 60/139 (43.2) 30/39 (76.9) 0.23(0.10–0.52) < 0.01 0.26(0.10–0.64) < 0.01 0.25 (0.07–0.83) 0.02 0.24(0.07–0.75) 0.02 †
Death at 90 days 29/139 (20.9) 3/39 (7.7) 3.16(0.91–11.01) 0.07 2.57(0.70–9.52) 0.16 3.36 (0.48–23.68) 0.22 2.99(0.46–19.74) 0.25 ‡
  1. Model 1 adjusted for age, sex, from vascular occlusion to puncture, NIHSS score
  2. Model 2 adjusted for age, sex, from vascular occlusion to puncture, NIHSS score, previous ischemic stroke, Mode of stroke onset, Blood glucose, Use of Solitaire retriever, Infusion of Tirofiban, Angioplasty
  3. GA indicates general anesthesia, CS conscious sedation, cOR crude odds ratio, aOR adjusted odds ratio, CI confidence interval, mRS modified Rankin Scale
  4. *Adjusted for age, sex, from vascular occlusion to puncture, NIHSS score, previous ischemic stroke, angioplasty, anesthesia time
  5. †Adjusted for age, sex, from vascular occlusion to puncture,NIHSS score, use solitaire retriever, blood glucose, anesthesia time
  6. ‡Adjusted for age, sex, from vascular occlusion to puncture, NIHSS score, previous ischemic stroke, blood glucose, use of solitaire, angioplasty, anesthesia time